Efficacy of Dapagliflozin Versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus. World Journal of Current Med and Pharm Research 2026, 8 (2), 185-189. https://doi.org/10.37022/wjcmpr.v8i2.415.